AIM: To identify the baseline characteristics associated with suppurative complications in children with community-acquired primary pneumonia. METHODS: A retrospective study included all children from 28 days to 15 years old, who presented with community-acquired pneumonia at two French hospitals from 1995 to 2003. Complicated pneumonia was defined by the presence of empyema and/or lung abscess. RESULTS: Of 767 children with community-acquired pneumonia, 90 had suppurative complications: 83 cases of pleural empyema and seven cases of lung abscess. The mean prevalence of complicated pneumonia was 3% during the 1995-1998 period, and then steadily increased following a linear trend to reach 23% in 2003. Children with complicated pneumonia were older and had a longer symptomatic period preceding hospitalization. They were more likely to receive antibiotics, especially aminopenicillins (p < 0.01), and nonsteroidal anti-inflammatory drugs, especially ibuprofen (p < 0.001). In multivariable analysis, ibuprofen was the only preadmission therapy that was independently associated with complicated pneumonia [adjusted OR = 2.57 (1.51-4.35)]. CONCLUSION: This study confirms an association between the use of prehospital ibuprofen and suppurative pneumonic complications.
AIM: To identify the baseline characteristics associated with suppurative complications in children with community-acquired primary pneumonia. METHODS: A retrospective study included all children from 28 days to 15 years old, who presented with community-acquired pneumonia at two French hospitals from 1995 to 2003. Complicated pneumonia was defined by the presence of empyema and/or lung abscess. RESULTS: Of 767 children with community-acquired pneumonia, 90 had suppurative complications: 83 cases of pleural empyema and seven cases of lung abscess. The mean prevalence of complicated pneumonia was 3% during the 1995-1998 period, and then steadily increased following a linear trend to reach 23% in 2003. Children with complicated pneumonia were older and had a longer symptomatic period preceding hospitalization. They were more likely to receive antibiotics, especially aminopenicillins (p < 0.01), and nonsteroidal anti-inflammatory drugs, especially ibuprofen (p < 0.001). In multivariable analysis, ibuprofen was the only preadmission therapy that was independently associated with complicated pneumonia [adjusted OR = 2.57 (1.51-4.35)]. CONCLUSION: This study confirms an association between the use of prehospital ibuprofen and suppurative pneumonic complications.
Authors: Aurélien Dinh; Maxime Jean; Frédérique Bouchand; Benjamin Davido; Alexis Descatha; Clara Duran; Guillaume Gras; Christian Perronne; Denis Mulleman; Jérôme Salomon; Louis Bernard Journal: Int J Rheumatol Date: 2016-10-19
Authors: Maurizio de Martino; Alberto Chiarugi; Attilio Boner; Giovanni Montini; Gianluigi L De' Angelis Journal: Drugs Date: 2017-08 Impact factor: 9.546
Authors: Joanna C Crocker; Meirion R Evans; Christopher C Butler; Kerenza Hood; Colin V E Powell Journal: BMJ Open Date: 2012-09-04 Impact factor: 2.692
Authors: Maria Regina Alves Cardoso; Cristiana Maria Costa Nascimento-Carvalho; Fernando Ferrero; Eitan Naaman Berezin; Raul Ruvinsky; Clemax Couto Sant'Anna; Maria Cristina de Cunto Brandileone; Maria de Fátima Bazhuni Pombo March; Ruben Maggi; Jesus Feris-Iglesias; Yehuda Benguigui; Paulo Augusto Moreira Camargos Journal: J Bras Pneumol Date: 2014 Jan-Feb Impact factor: 2.624
Authors: Eduardo Jf Lima; Maria Jg Mello; Maria Fpm Albuquerque; Maria Il Lopes; George Hc Serra; Maria Az Abreu-Lima; Jailson B Correia Journal: Pediatric Health Med Ther Date: 2015-08-24